Ingevity (NGVT) Stock May Be Above Fair Value Following Germany Approval

Ingevity Corp shares may be overvalued despite the positive regulatory approval of Evotherm P35 in Germany. Analysts note the stock's future depends on sustaining demand in higher-value applications beyond its recent 61.9% surge.